Trial
NCT05661669
Ketamine for the Treatment for Alcohol Use Disorder in the ED
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Alcohol Use Disorder
Intervention
Ketamine
Why stopped
After months of screening, we screened 175 individuals, only 3 were eligible, 2 declined, and 1 was moved to a different floor before study activities were able to take place.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-08